Skip to content
Upcoming events
AEEDC Dubai 202719–21 January 2027World Health Expo (WHX) Dubai 202725–28 January 2027ChinaDental South China 20273–6 March 2027GermanyIDS 2027 — International Dental Show16–20 March 2027United StatesAAD Annual Meeting 202719–23 March 2027Dubai Derma 20276–8 April 2027Dental-Expo Moscow Spring 202726–29 April 2027France7th World Congress of Dermoscopy12–15 May 2027GermanyEADV Symposium 202720–22 May 2027United StatesASCO Annual Meeting 20274–8 June 2027ChinaSino-Dental 20279–12 June 2027White Nights 2027 — St. Petersburg International Oncology ForumUsually early JulyArmenian Medical World Congress 20278–10 July 2027Dental-Expo Moscow 2027Usually late SeptemberNetherlandsEADV Congress 202722–25 September 2027SpainEAO Congress 202723–25 September 2027CanadaCFAS Annual Meeting 202723–25 September 2027Russian Health Care Week 2027Usually December
Internal Medicine

Common osteoporosis drugs linked to up to 24% lower dementia risk

A medical professional closely examines a leg X-ray, pointing out details with a pen.

Key facts

  • More than 120,000 older adults were included.
  • People taking common osteoporosis drugs had up to 24% lower risk of Alzheimer’s disease and other dementias.
  • The study is observational: it shows an association, not proof that the drugs prevent dementia.

What happened

A large study of more than 120,000 older adults found that people who used common osteoporosis medicines had a lower risk of developing Alzheimer’s disease and other forms of dementia — up to 24% lower than people who did not use them. The researchers suggest that medicines already widely prescribed to protect bones might also have effects that matter for the brain.

Why it matters

Dementia and osteoporosis often affect the same older patients, and both are rising as populations age. If the link holds up in randomised trials, drugs that are already approved, inexpensive and familiar to doctors could become part of dementia-prevention research. For now, the finding does not change who should take these medicines: they are prescribed to prevent fractures, not dementia.

Observational studies can be influenced by other differences between groups. People who are prescribed and keep taking long-term preventive treatment may be healthier or have better access to care. Researchers adjust for such factors, but only randomised trials can show cause and effect.

Background: how could bone drugs affect the brain?

The most widely used osteoporosis medicines, bisphosphonates, slow down the cells that break down bone. Researchers have proposed several ways such drugs might influence brain health, including effects on inflammation and on blood vessels, and the possibility that preventing fractures helps older people stay active and independent — itself linked to better cognitive health. None of these explanations has been proven yet, which is why randomised trials are the next step.

What it means for clinicians and students

  • Physicians: a reason to watch for trial data, not to prescribe osteoporosis drugs for brain health.
  • Dentists and oral surgeons: many older patients take antiresorptive drugs such as bisphosphonates or denosumab. Before extractions, implants or other surgery, always record these medicines and assess the risk of medication-related osteonecrosis of the jaw (MRONJ), which is rare but serious.
  • Students: a good example of why “associated with” is not the same as “prevents”.

Related reading: Dental implants and bone grafting.

Source: ScienceDaily